Revolution Medicines, Inc. (RVMD)
98.40
-1.24
(-1.24%)
USD |
NASDAQ |
Mar 06, 16:00
98.50
+0.10
(+0.10%)
After-Hours: 20:00
Revolution Medicines SG&A Expense (TTM) : 195.04M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Merck & Co., Inc. | 10.73B |
| AbbVie, Inc. | 14.01B |
| Tango Therapeutics, Inc. | 31.74M |
| Insmed, Inc. | 701.17M |